Deficiency in X-linked inhibitor of apoptosis protein promotes susceptibility to microbial triggers of intestinal inflammation.


Journal

Science immunology
ISSN: 2470-9468
Titre abrégé: Sci Immunol
Pays: United States
ID NLM: 101688624

Informations de publication

Date de publication:
05 Nov 2021
Historique:
entrez: 5 11 2021
pubmed: 6 11 2021
medline: 8 3 2022
Statut: ppublish

Résumé

Inflammatory bowel disease (IBD) is characterized by inappropriate immune responses to the microbiota in genetically susceptible hosts, but little is known about the pathways that link individual genetic alterations to microbiota-dependent inflammation. Here, we demonstrated that the loss of X-linked inhibitor of apoptosis protein (XIAP), a gene associated with Mendelian IBD, rendered Paneth cells sensitive to microbiota-, tumor necrosis factor (TNF)–, receptor-interacting protein kinase 1 (RIPK1)–, and RIPK3-dependent cell death. This was associated with deficiency in Paneth cell–derived antimicrobial peptides and alterations in the stratification and composition of the microbiota. Loss of XIAP was not sufficient to elicit intestinal inflammation but provided susceptibility to pathobionts able to promote granulomatous ileitis, which could be prevented by administration of a Paneth cell–derived antimicrobial peptide. These data reveal a pathway critical for host-microbial cross-talk, which is required for intestinal homeostasis and the prevention of inflammation and which is amenable to therapeutic targeting.

Identifiants

pubmed: 34739342
doi: 10.1126/sciimmunol.abf7473
doi:

Substances chimiques

Antimicrobial Peptides 0
Birc4 protein, mouse 0
Inhibitor of Apoptosis Proteins 0
X-Linked Inhibitor of Apoptosis Protein 0
XIAP protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eabf7473

Subventions

Organisme : NIDDK NIH HHS
ID : RC2 DK118640
Pays : United States

Commentaires et corrections

Type : CommentIn

Auteurs

Anne Strigli (A)

Center for Regenerative Therapies, Technische Universität (TU) Dresden, 01307 Dresden, Germany.
Department of Medicine I, University Medical Center Dresden, Technische Universität (TU) Dresden, 01307 Dresden, Germany.

Shreya Gopalakrishnan (S)

Center for Regenerative Therapies, Technische Universität (TU) Dresden, 01307 Dresden, Germany.
Department of Medicine I, University Medical Center Dresden, Technische Universität (TU) Dresden, 01307 Dresden, Germany.

Yvonne Zeissig (Y)

Department of General Pediatrics, University Medical Center Dresden, Technische Universität (TU) Dresden, 01307 Dresden, Germany.

Marijana Basic (M)

Institute for Laboratory Animal Science, Hannover Medical School, 30625 Hannover, Germany.

Jun Wang (J)

Max Planck Institute for Evolutionary Biology, 24306 Plön, Germany.
Institute for Experimental Medicine, Kiel University, 24105 Kiel, Germany.
CAS Key Laboratory for Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.

Tobias Schwerd (T)

Department of Pediatrics, Dr von Hauner Children's Hospital, LMU Munich, 80337 Munich, Germany.

Shauni Doms (S)

Max Planck Institute for Evolutionary Biology, 24306 Plön, Germany.
Institute for Experimental Medicine, Kiel University, 24105 Kiel, Germany.

Kenneth Peuker (K)

Center for Regenerative Therapies, Technische Universität (TU) Dresden, 01307 Dresden, Germany.
Department of Medicine I, University Medical Center Dresden, Technische Universität (TU) Dresden, 01307 Dresden, Germany.

Jelka Hartwig (J)

Center for Regenerative Therapies, Technische Universität (TU) Dresden, 01307 Dresden, Germany.

Jürgen Harder (J)

Department of Dermatology, University Medical Center Schleswig-Holstein, 24105 Kiel, Germany.

Pia Hönscheid (P)

Institute of Pathology, University Medical Center Dresden, Technische Universität (TU) Dresden, 01307 Dresden, Germany.

Philipp Arnold (P)

Institute of Functional and Clinical Anatomy, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.

Thomas Kurth (T)

Center for Molecular and Cellular Bioengineering (CMCB), Technology Platform, Technische Universität (TU) Dresden, 01307 Dresden, Germany.

Fabian Rost (F)

Center for Molecular and Cellular Bioengineering (CMCB), Technology Platform, Technische Universität (TU) Dresden, 01307 Dresden, Germany.
Center for Information Services and High Performance Computing (ZIH), Technische Universität (TU) Dresden, 01602 Dresden, Germany.

Britt-Sabina Petersen (BS)

Institute for Clinical Molecular Biology, Kiel University, 24105 Kiel, Germany.

Michael Forster (M)

Institute for Clinical Molecular Biology, Kiel University, 24105 Kiel, Germany.

Andre Franke (A)

Institute for Clinical Molecular Biology, Kiel University, 24105 Kiel, Germany.

Judith R Kelsen (JR)

Division of Gastroenterology, Hepatology, and Nutrition, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Meino Rohlfs (M)

Department of Pediatrics, Dr von Hauner Children's Hospital, LMU Munich, 80337 Munich, Germany.

Christoph Klein (C)

Department of Pediatrics, Dr von Hauner Children's Hospital, LMU Munich, 80337 Munich, Germany.

Aleixo M Muise (AM)

SickKids Inflammatory Bowel Disease Center, Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.
Cell Biology Program, Research Institute, Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.
Department of Pediatrics, Institute of Medical Science and Biochemistry, University of Toronto, Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.

Neil Warner (N)

SickKids Inflammatory Bowel Disease Center, Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.

Ryusuke Nambu (R)

SickKids Inflammatory Bowel Disease Center, Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.
Division of Gastroenterology and Hepatology, Saitama Children's Medical Center, Saitama 330-8777, Japan.

Julia Mayerle (J)

Department of Medicine II, University Hospital, LMU Munich, 80337 Munich, Germany.

Helga-Paula Török (HP)

Department of Medicine II, University Hospital, LMU Munich, 80337 Munich, Germany.

Andreas Linkermann (A)

Division of Nephrology, Department of Medicine III, University Medical Center Dresden, Technische Universität (TU) Dresden, 01307 Dresden, Germany.

Michael H Muders (MH)

Institute of Pathology, University Medical Center Dresden, Technische Universität (TU) Dresden, 01307 Dresden, Germany.

Gustavo B Baretton (GB)

Institute of Pathology, University Medical Center Dresden, Technische Universität (TU) Dresden, 01307 Dresden, Germany.

Jochen Hampe (J)

Center for Regenerative Therapies, Technische Universität (TU) Dresden, 01307 Dresden, Germany.
Department of Medicine I, University Medical Center Dresden, Technische Universität (TU) Dresden, 01307 Dresden, Germany.

Daniela E Aust (DE)

Institute of Pathology, University Medical Center Dresden, Technische Universität (TU) Dresden, 01307 Dresden, Germany.
Tumor and Normal Tissue Bank of the University Cancer Center (UCC), University Medical Center Dresden, Technische Universität (TU) Dresden, 01307 Dresden, Germany.

John F Baines (JF)

Max Planck Institute for Evolutionary Biology, 24306 Plön, Germany.
Institute for Experimental Medicine, Kiel University, 24105 Kiel, Germany.

André Bleich (A)

Institute for Laboratory Animal Science, Hannover Medical School, 30625 Hannover, Germany.

Sebastian Zeissig (S)

Center for Regenerative Therapies, Technische Universität (TU) Dresden, 01307 Dresden, Germany.
Department of Medicine I, University Medical Center Dresden, Technische Universität (TU) Dresden, 01307 Dresden, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH